Masimo Corporation

Masimo Corporation, a for-profit medical technology manufacturer headquartered in Irvine, California, operates as a prime contractor supplying noninvasive patient monitoring equipment and consumables to the Defense Logistics Agency and Veterans Health Administration, competing under full-and-open procurement with no set-aside designations across a portfolio of 5,276 federal awards valued at $1.25 billion combined potential value.

Masimo manufactures and delivers pulse oximeters, capnographs, adhesive sensors, respiratory monitoring accessories, and related diagnostic equipment—concrete product categories grounded in representative delivery orders from the Defense Logistics Agency Medical Supply Chain. Recent awards include a $55,781 delivery order (January 28, 2026) for O3 Regional Oximeter kits, a $31,200 delivery order (March 20, 2026) for CAPNOMETER EMMA 1S equipment, and a $24,485 delivery order (March 6, 2026) for MightySat pulse oximeters, all placed against the company's indefinite delivery contract SPE2D121D7001. The company also holds a single-award Blanket Purchase Agreement with Veterans Integrated Service Network 1 established March 9, 2022, running through July 14, 2030, for medical supplies under the Medical Surgical Prime Vendor Program.

Customer concentration is extreme. The Defense Logistics Agency Troop Support Medical accounts for 4,144 awards (78% of the portfolio) with $1.15 billion in combined potential value—or 92% of all dollars across the entire customer base. The top five funding agencies by award count represent 82% of all awards; the top five by potential value represent 94% of combined dollars. This concentration reflects Masimo's establishment as a routine supplier of medical consumables to federal healthcare operations, particularly for military and veteran facilities. The Department of Veterans Affairs Veterans Health Administration operates across multiple Veterans Integrated Service Networks as a secondary customer base (76 awards across VISN 9 alone, $750 thousand potential value), and the Department of Health and Human Services Indian Health Service accounts for 44 awards ($3.6 million potential value).

The company places work through five primary parent vehicles. The Indefinite Delivery Contract SPE2D121D7001 carries 2,839 task orders ($10.8 million combined potential value), functioning as the DLA's core vehicle for routine medical supply replenishment. The DLA Medical Capital Equipment Program issued 1,237 task orders ($6.1 million combined potential value) for larger-dollar medical equipment procurements. The Federal Supply Schedule V797P4527A, a GSA Schedule position, accounts for 844 task orders ($8 million combined potential value). A Medical Equipment and Supplies vehicle delivered 87 task orders ($45.2 million combined potential value), representing higher-value, episodic procurements distinct from routine replenishment. A Blanket Purchase Agreement (V797P4527A-HHSI245200530117B) carries 7 task orders ($8 thousand combined potential value).

Award activity has grown sharply. The source records 383 awards in 2022, accelerating to 482 in 2023, 899 in 2024, 700 in 2025, and 272 in the first quarter of 2026. This trajectory reflects scaling of medical supply orders across the federal healthcare system, particularly through the DLA Medical Supply Chain. The most recent award dates to April 15, 2026. Only 3% of combined potential value has been obligated as of the snapshot date, indicating a large pipeline of task orders yet to be fulfilled across the IDIQ portfolio.

Product classification is two-part. By NAICS, 4,097 awards (78% of the portfolio) fall under Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (424512), reflecting the company's role as a supplier and distributor; 960 awards are classified as Surgical and Medical Instrument Manufacturing (339112), capturing Masimo's own manufacturing. By PSC code, 3,570 awards (68%) are coded to Imaging Equipment and Supplies—Medical, Dental, Veterinary (6515), and 1,517 awards are Medical and Surgical Instruments, Equipment, and Supplies (6520), affirming equipment and consumable supply as the operational reality.

Masimo does not appear in the source as a subcontractor; the sub-award split is 0%. The company holds a named subsidiary, Masimo Americas, Inc., a for-profit manufacturer, but the source does not characterize its distinct federal role.

The recompete environment is fluid but not acute at present. The source does not furnish a discrete recompete cliff window. However, the VISN 1 BPA runs through July 14, 2030—over four years from the snapshot date—and the DLA indefinite delivery contracts typically carry multi-year terms. The rapid growth in annual award volume (2022–2024) suggests renewed or expanded vehicle positions or increased task order frequency rather than imminent recompete exposure in the next twelve to twenty-four months, though vendor intelligence should confirm expiration dates on the top three parent vehicles.